Novavax Confirms High Levels of Efficacy Against Original and Variant COVID-19 Strains in United Kingdom and South Africa Trialshttps://ir.novavax.com/news-releases/news-release-details/novavax-confirms-high-levels-efficacy-against-original-and?sf140129199=1
Moderna Announces it has Shipped Variant-Specific Vaccine Candidate, mRNA-1273.351, to NIH for Clinical Studyhttps://investors.modernatx.com/news-releases/news-release-details/moderna-announces-it-has-shipped-variant-specific-vaccine/
Novavax to Host Conference Call to Discuss Fourth Quarter Financial Results and Operational Highlights on March 1, 2021https://ir.novavax.com/news-releases/news-release-details/novavax-host-conference-call-discuss-fourth-quarter-financial-0